BRIEF-Health Canada Permits COVID-19 Patients With Respiratory Failure To Be Given Nuvox Pharma’s Oxygen Therapeutic In Segment Iia Clinical Trial

June 29 (Reuters) – Nuvox Pharma: HEALTH CANADA ALLOWS COVID-19 PATIENTS WITH RESPIRATORY FAILURE TO BE GIVEN NUVOX PHARMA’S OXYGEN THERAPEUTIC IN PHASE IIA CLINICAL…